89 - First-in-human study of a novel half-life extended monoclonal antibody (GB-0669) against SARS-CoV2 and related sarbecoviruses

Thursday, October 17, 2024

10:54 AM – 11:06 AM US PT

Location: 411

Presenting Author(s)

Dinesh De Alwis, PhD (he/him/his)

SVP, Clinical Drug Development
Generate Biomedicines
New York, NY, United States

Slides

Co-Author(s)

Francesco Borriello, MD PhD (he/him/his)

Associate Director
Generate Biomedicines
Lexington, Massachusetts, United States
EC

Eric Carlin, PhD

Scientist
Generate Biomedicines
Somerville, Massachusetts, United States
RN

Rounak Nassirpour, PhD

Generate Biomedicines
Somerville, Massachusetts, United States
SS

Stephanie Straley, PA-C

Sr. Director
Generate Biomedicines
Golden, Colorado, United States
AA

Anna Allen, n/a

Sr. Clinical Trial Manager
Generate Biomedicines
Somerville, Massachusetts, United States
AR

Andrew W. Robertson, n/a

Senior Director
Generate Biomedicines
San Francisco, California, United States
IT

Iñaki F. Troconiz, Pharmacy

Professor
University of Navarra
Pamplona, Navarra, Spain
AS

Akber Safder, DO

Associate Medical Director Clinical Operations, Principal Inviestigator
PPD part of Thermofisher
Orlando, Florida, United States
DH

Daria Hazuda, PhD

Head of Infectious Diseases
Generate Biomedicines
Henderson, Nevada, United States
LG

Lovely Goyal, Ph.D.

Executive Director, Biometrics
Generate Biomedicines
Irvine, California, United States
GK

Gavin CKW Koh, PhD

Executive Director
Generate:Biomedicines
Somerville, Massachusetts, United States
NR

Nicholas Robertson, M.S.

Generate Biomedicines
Somerville, Massachusetts, United States
AS

Alexandra Snyder, MD

Generate Biomedicines
New York, New York, United States

Disclosure(s):

Dinesh De Alwis, PhD: Generate Biomedicines: Stocks/Bonds (Private Company)

Francesco Borriello, MD PhD: No financial relationships to disclose

Eric Carlin, PhD: No financial relationships to disclose

Rounak Nassirpour, PhD: No financial relationships to disclose

Stephanie Straley, PA-C: No financial relationships to disclose

Anna Allen, n/a: No financial relationships to disclose

Andrew W. Robertson, n/a: No financial relationships to disclose

Iñaki F. Troconiz, Pharmacy: Generate Biomedicines: Advisor/Consultant

Akber Safder, DO: No financial relationships to disclose

Daria Hazuda, PhD: Generate Biomedicines: Stocks/Bonds (Private Company)

Lovely Goyal, Ph.D.: No financial relationships to disclose

Gavin CKW Koh, PhD: AstraZeneca: Stocks/Bonds (Public Company); Generate:Biomedicines: Stocks/Bonds (Private Company); GlaxoSmithKline: Stocks/Bonds (Public Company)

Nicholas Robertson, M.S.: No financial relationships to disclose

Alexandra Snyder, MD: Generate Biomedicines: employee